The IPO 4-1-1: Four fil­ings, a pric­ing and a with­draw­al head­line this week's Nas­daq ac­tion as raise ap­proach­es $7.5B

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

An­oth­er week, an­oth­er horde of biotechs is do­ing the Nas­daq dance.

This week saw four com­pa­nies file their SEC pa­per­work ahead of ex­pect­ed de­buts, an­oth­er hit Nas­daq on Fri­day and a sixth for­mal­ly with­drew its bid to go pub­lic. Aerovate Ther­a­peu­tics, Ocean Bio­med­ical and Acu­men Phar­ma­ceu­ti­cals all pen­ciled in ini­tial rais­es of $100 mil­lion, while Der­ma­ta Ther­a­peu­tics is es­ti­mat­ing a mod­est $18 mil­lion raise.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA